Clinical effect of white matter network disruption related to amyloid and small vessel disease
Citation Manager Formats
Make Comment
See Comments

Abstract
Background: We tested our hypothesis that the white matter network might mediate the effect of amyloid and small vessel disease (SVD) on cortical thickness and/or cognition.
Methods: We prospectively recruited 232 patients with cognitive impairment. Amyloid was assessed using Pittsburgh compound B–PET. SVD was quantified as white matter hyperintensity volume and lacune number. The regional white matter network connectivity was measured as regional nodal efficiency by applying graph theoretical analysis to diffusion tensor imaging data. We measured cortical thickness and performed neuropsychological tests.
Results: SVD burden was associated with decreased nodal efficiency in the bilateral frontal, lateral temporal, lateral parietal, and occipital regions. Path analyses showed that the frontal nodal efficiency mediated the effect of SVD on the frontal atrophy and frontal-executive dysfunction. The temporoparietal nodal efficiency mediated the effect of SVD on the temporoparietal atrophy and memory dysfunction. However, Pittsburgh compound B retention ratio affected cortical atrophy and cognitive impairment without being mediated by nodal efficiency.
Conclusions: We suggest that a disrupted white matter network mediates the effect of SVD, but not amyloid, on specific patterns of cortical atrophy and/or cognitive impairment. Therefore, our findings provide insight to better understand how amyloid and SVD burden can give rise to brain atrophy or cognitive impairment in specific patterns.
GLOSSARY
- AAL=
- automated anatomical labeling;
- AD=
- Alzheimer disease;
- aMCI=
- amnestic mild cognitive impairment;
- DSM-IV=
- Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition);
- DTI=
- diffusion tensor imaging;
- FLAIR=
- fluid-attenuated inversion recovery;
- MNI=
- Montreal Neurological Institute;
- PiB=
- Pittsburgh compound B;
- SVaD=
- subcortical vascular dementia;
- SVD=
- small vessel disease;
- svMCI=
- subcortical vascular mild cognitive impairment;
- WM=
- white matter;
- WMH=
- white matter hyperintensity
Alzheimer disease (AD) is characterized by accumulation of β-amyloid plaques and temporoparietal atrophy, resulting in memory dysfunction.1,2 Subcortical vascular dementia (SVaD) is typically identified by extensive small vessel disease (SVD) markers and frontal atrophy, resulting in frontal-executive dysfunction.3 However, it remains unknown how atrophy in specific regions or cognitive impairment in specific domains arises from amyloid and SVD burden, the 2 most commonly coexisting pathologies in patients with dementia.4,5
Graph theoretical analysis using diffusion tensor imaging (DTI) data can facilitate examination of large-scale white matter (WM) connectivity of the human brain from a network perspective.6 There is increasing evidence that patients with AD and SVD demonstrate a disrupted WM network.7,–,9 However, the clinical effect of WM network disruption related to amyloid and SVD remains unknown. With the following evidence, we suggest that the WM network might be a key link between amyloid/SVD burden and cortical atrophy or cognitive impairment: (1) alteration in the WM network was associated with cognitive impairment,10 (2) propagation of amyloid fibrils and progression of brain atrophy occurred along WM fiber pathways,11 and (3) the topography of cortical atrophy related to WM hyperintensity (WMH) was similar to cortical regions connected via WM tracts, suggesting that cortical regions that are interconnected via the damaged tracts might become atrophic.12
We tested the hypothesis that the WM network might be a key link between amyloid/SVD burden and cortical atrophy or cognitive impairment. We then performed path analyses to evaluate whether the WM network mediates the association between amyloid/SVD burden and cortical atrophy or cognition.
METHODS
Participants.
We prospectively recruited 251 participants with cognitive impairment who underwent Pittsburgh compound B (PiB)-PET and structural brain MRI, from July 2007 to July 2011. All participants were clinically diagnosed at Samsung Medical Center. Patients with amnestic mild cognitive impairment (aMCI, n = 45) and those with subcortical vascular mild cognitive impairment (svMCI, n = 67) met the Petersen criteria for mild cognitive impairment with modifications.13 Patients with probable AD dementia (n = 69) met criteria proposed by the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association.14 Patients with SVaD (n = 70) met the diagnostic criteria for vascular dementia as determined by the DSM-IV, and also met the imaging criteria for SVaD proposed by Erkinjuntti et al.15 Patients with svMCI and SVaD had severe WMH on fluid-attenuated inversion recovery (FLAIR) images, which was defined as periventricular WMH ≥10 mm and deep WMH ≥25 mm, as modified from the Fazekas ischemia criteria.16 Patients with aMCI and AD were classified as having minimal (periventricular WMH <5 mm and deep WMH <5 mm) or moderate WMH (between minimal and severe WMH). The WMH meets the definition of WMH of presumed vascular origin, recently proposed by Wardlaw et al.17
Patients with territorial infarctions, WMH due to radiation injury, leukodystrophy, multiple sclerosis, or vasculitis were excluded. All patients underwent a clinical interview and neurologic examination. In addition, complete blood count, blood chemistry, vitamin B12/folate level, syphilis serology, thyroid function, and APOE genotype were tested through blood sample.
Standard protocol approvals, registrations, and patient consents.
This study was approved by the institutional review board of Samsung Medical Center. We obtained written consent from each patient.
PiB-PET acquisition and data analysis.
All patients completed an [11C]PiB-PET scan at Samsung Medical Center or Asan Medical Center. All participants completed the same type of PET scan with a Discovery STe PET/CT scanner (GE Medical Systems, Milwaukee, WI). When measuring PiB retention, cerebellar gray matter was used as the reference region. We defined the PiB retention ratio as a continuous variable representing amyloid burden. The detailed radiochemistry profiles, scanning protocol, and PiB-PET data analysis are described in appendix e-1 on the Neurology® Web site at Neurology.org and in a previous study.5
MRI techniques.
We acquired standardized T2, 3-dimensional T1 turbo field echo, 3-dimensional FLAIR, and DTIs from all participants at Samsung Medical Center using the same 3.0T MRI scanner (Philips 3.0T Achieva; Philips Healthcare, Andover, MA). Detailed imaging parameters are described in appendix e-2. In whole-brain DTI-MRI examination, sets of axial diffusion-weighted single-shot echo-planar images were collected with the following parameters: 128 × 128 acquisition matrix; 1.72 × 1.72 × 2 mm3 voxel size; 70 axial slices; 22 × 22 cm2 field of view; echo time 60 milliseconds, repetition time 7,696 milliseconds; flip angle 90°; slice gap 0 mm; b-factor of 600 s/mm2. Diffusion-weighted images were acquired from 45 different directions using the baseline image without weighting (0, 0, 0). All axial sections were acquired parallel to the anterior commissure–posterior commissure line.
Measurement of WMH volume and lacunes.
We measured volume of WMH (in milliliters) on FLAIR images using an automated method.18 Detailed methods are described in appendix e-3.
A lacune was defined as a lesion ≥3 mm and ≤15 mm in diameter with low signal on T1-weighted images, high signal on T2-weighted images, and perilesional halo on FLAIR images. This meets the definition of lacune of presumed vascular origin, recently proposed by Wardlaw et al.17 Two neurologists manually counted the number of lacunes, with a κ value of 0.78.
Network node definition.
We used the automated anatomical labeling (AAL) atlas19 to parcellate the entire cerebral cortex into 78 areas (39 regions in each hemisphere) and to define the nodes of a brain graph. Individual T1-weighted images were nonlinearly registered to the ICBM152 T1 template in Montreal Neurological Institute (MNI) space.20 The AAL atlas was transformed from MNI space to T1 native space using the inverse transformation with a nearest-neighbor interpolation method.
Network edge definition.
We corrected distortions in DTIs caused by eddy currents and simple head motions by using the diffusion toolbox of the FSL (FMRIB's Software Library) package (www.fmrib.ox.ac.uk/fsl/fdt). Diffusion tensor models were estimated, and fractional anisotropy and mean diffusivity were calculated at each voxel. Whole-brain WM fiber tracts in native diffusion space for each participant were reconstructed using fiber assignment by a continuous tracking algorithm21 that is embedded in the Diffusion Toolkit (trackvis.org).22 Tracking was terminated when the angle between 2 consecutive orientation vectors was greater than 45°, or when both ends of the fibers extended outside of the WM mask that was generated by the tissue segmentation process.23,24 A fiber cutoff filter was applied so that fibers shorter than 20 mm and longer than 200 mm were filtered.
Using the affine registration tool from the FSL package (www.fmrib.ox.ac.uk/fsl/flirt), we coregistered T1-weighted images to the b0 images. Reconstructed whole-brain fiber tracts were inversely transformed into T1 space and fiber tracts and AAL-based parcellated regions were located in the same space. We assume that 2 nodes (regions) were structurally connected by an edge when at least the end points of 3 fiber tracts were located in these 2 regions. We selected a threshold number of fiber tracts to reduce the risk of false-positive connections due to noise or limitations of deterministic tractography.24,25 In this study, a mean fractional anisotropy value along all the fibers connecting a pair of regions was used to weight the edge. Finally, weighted WM networks represented by symmetric 78 × 78 matrices were constructed for each individual.
Network analysis.
Graph theoretical analyses were performed on weighted connectivity networks using the Brain Connectivity Toolbox (www.brain-connectivity-toolbox.net).26 We used nodal efficiency as a nodal topological characteristic. Nodal efficiency is defined using the inverse of the weighted shortest path length between a given node and all other nodes in the network.26 This metric quantifies the importance of nodes for communication within the network. Nodal efficiency was measured for each node, and averaged values of the nodal efficiency (mean nodal efficiency) in the frontal and temporoparietal regions predefined in the AAL atlas were used for global analysis.
Of 251 participants, we excluded 6 patients for whom WMH volume measurement failed because of segmentation errors, and 13 for whom the quality of diffusion image (low signal-to-noise ratio) was not sufficient to reconstruct reliable fiber tracts. Thus, network analysis was performed in 232 participants.
Cortical thickness data analysis.
T1-weighted images were processed using the standard MNI anatomical pipeline. Further image processing for cortical thickness measurements is described in appendix e-4. In this way, we obtained the mean thickness of the frontal lobe and temporoparietal lobe.
Neuropsychological tests.
Participants underwent neuropsychological tests using a standardized neuropsychological battery.27 Based on the neuropsychological results, we calculated memory and frontal-executive subdomain scores.28 Memory-domain score (memory score) was calculated by summing scores in orientation, verbal memory, and visual memory tests. The memory score ranged from 0 to 150. Frontal-executive-domain score (executive score) was calculated by summing scores in a category word generation task, a phonemic word generation task, and the Stroop color reading test. The executive score ranged from 0 to 55.
Because of missing data in the memory score (n = 10) and executive score (n = 21), path analysis for the memory score was performed with data from 222 patients, and path analysis for the executive score was performed with data from 211 patients.
Statistical analysis.
To evaluate the association between neuroimaging markers (PiB retention ratio, WMH volume, lacune number) and nodal efficiency, multiple linear regression analysis was performed for each node. We entered age, sex, education, PiB retention ratio, WMH volume, and lacune number to find the independent effects of each imaging marker. False discovery rate correction was performed to correct for multiple comparisons in 78 node regions.
To evaluate whether alteration of the WM network mediates the effects of SVD markers and amyloid burden on cortical thickness and cognition, path analyses were performed after controlling for age, sex, and education. Path analysis was used to simultaneously consider the direct, indirect, and total effects of predictors on outcomes through mediators. Because our intention was to focus on frontal-executive and memory function, we selected nodes or cortical regions that were related to frontal-executive function (bilateral frontal lobe) when evaluating frontal-executive function, and selected nodes or cortical regions that were related to memory (bilateral temporal and parietal lobe) when evaluating memory function (appendix e-5). Path analysis using executive score as the outcome was performed using mean frontal nodal efficiency and mean frontal thickness as mediators (path analysis A). Path analysis using memory score as the outcome was performed using mean temporoparietal nodal efficiency and mean temporoparietal thickness as mediators (path analysis B). The pathobiological model of complex relationships between various factors is shown in figure e-1. We also performed subgroup analyses in patients with aMCI and AD (appendix e-6, table e-1, figure e-2). Amos version 18.0 software (SPSS, Chicago, IL) was used for all path analyses using maximum likelihood estimation.
RESULTS
Demographics.
The characteristics of our study participants are shown in table 1.
Demographics of participants
Decreased regional nodal efficiency related to SVD or amyloid burden.
Increased WMH volume was associated with decreased nodal efficiency in the bilateral frontal, lateral temporal, lateral parietal, and occipital regions sparing the medial temporal and precuneus regions (figure 1A, table e-2). Increased number of lacunes was associated with decreased nodal efficiency in the left frontal, lateral temporal, and right lateral parietal regions (figure 1B, table e-2). There were no regions where PiB retention ratio was associated with decreased nodal efficiency.
Statistically significant nodes are colored in red (false discovery rate–corrected p < 0.05). The size of the node sphere represents a standardized regression coefficient. WMH = white matter hyperintensities.
Path analyses.
Prediction of frontal-executive function and frontal cortical thickness.
The path analysis for executive score showed goodness of fit to the data: χ2 = 14.65, degrees of freedom = 9, p = 0.101, comparative fit index = 0.986, and root-mean-square error of approximation = 0.055 (table 2, figure 2A). Increased WMH volume and lacunes were associated with decreased mean frontal nodal efficiency, which was further associated with decreased mean frontal thickness that led to decreased executive score. Decreased mean frontal nodal efficiency was associated with decreased executive score without being mediated by frontal thickness. Increased number of lacunes was associated with decreased executive score without being mediated by frontal nodal efficiency or thickness. Increased PiB retention ratio was associated with decreased executive score without being mediated by frontal nodal efficiency.
Effects of predictors (WMH volume, number of lacunes, and PiB retention ratio) on frontal-executive and memory function through mediators (mean nodal efficiency and mean cortical thickness)
White matter hyperintensity (WMH) volume, lacune number, and amyloid burden were entered as predictors. Mean nodal efficiency and mean cortical thickness in specific regions were entered as mediators. Age, sex, and education were entered as covariates. Numbers on the paths are standardized coefficients that were statistically significant.
Prediction of memory function and temporoparietal cortical thickness.
The path analysis for memory score showed goodness of fit to the data: χ2 = 13.93, degrees of freedom = 10, p = 0.176, comparative fit index = 0.991, and root-mean-square error of approximation = 0.042 (table 2, figure 2B). Increased WMH volume and lacunes were associated with decreased mean temporoparietal nodal efficiency, which in turn was associated with decreased mean temporoparietal thickness, which led to decreased memory score. In contrast to WMH or lacunes, PiB retention ratio affected memory score without being mediated by nodal efficiency. Increased PiB retention ratio was associated with decreased mean temporoparietal thickness, which in turn was associated with decreased memory score. Increased PiB retention ratio was also associated with decreased memory score without being mediated by temporoparietal nodal efficiency or thickness.
We also investigated these relationships using nodal strength, which is another local measure. The results were generally similar to those of nodal efficiency (figures e-3 and e-4, table e-3).
DISCUSSION
The present study examined the clinical effect of WM network disruption related to amyloid and SVD burdens. Our major findings were as follows: (1) SVD burden was associated with decreased nodal efficiency in widespread regions sparing medial temporal and precuneus regions, while there were no regions where amyloid burden was related to nodal efficiency; (2) SVD burden resulted in frontal or temporoparietal atrophy and frontal-executive or memory dysfunction via disruption of the corresponding WM network; and (3) amyloid burden affected cortical atrophy and cognitive impairment without being mediated by the WM network. Taken together, our findings suggest that alteration of the WM network mediates the effects of SVD burden on cortical atrophy and/or cognitive impairment. Furthermore, our findings provide insight to better understand how amyloid and SVD burden can give rise to brain atrophy in specific patterns or cognitive impairment in specific domains.
Our first major finding was that WMH were associated with decreased nodal efficiency in widespread regions. Several studies have already shown relationships between SVD markers and WM injury.29,30 However, to our knowledge, only a few studies have evaluated these relationships from a regional network perspective.8 Nodal efficiency, one of the network parameters, quantifies the importance of each node for communication within a network. As expected, WMH mostly affected nodal efficiency in the frontal regions. This is consistent with a previous study, which showed that WMH were associated with frontal hypometabolism or frontal-executive dysfunction regardless of their locations.31 In addition to the frontal regions, larger WMH volume was associated with decreased nodal efficiency in the lateral temporal and lateral parietal regions. This is supported by a recent study showing that WMH were associated with memory, language, and visuospatial dysfunctions as well as frontal-executive dysfunction.32 Of note, the topography of decreased nodal efficiency related to WMH relatively spared the medial temporal or precuneus regions. Previous studies have shown that the precuneus is a major hub region in the brain33 and is involved in the early stage of AD.34,35 However, the current results might be supported by our previous study, which showed that patients with svMCI or SVaD who had profound WMH, but no significant amyloid burdens, had the entire cortical atrophy with the exception of the precuneus.36 Furthermore, regions of decreased nodal efficiency related to WMH overlapped with regions of cortical atrophy related to WMH.12 Therefore, it is conceivable that disruption of the WM network by WMH might be related to the development of cortical atrophy. Moreover, sparing of precuneus might be a feature discriminating patients with pure svMCI or pure SVaD from those with AD pathologies.
We found that the regional effects of lacunes on nodal efficiency were less widespread than those of WMH. This might be explained by differences in the regional involvement of the 2 SVD markers. That is, most lacunes occur focally in subcortical gray matter, while WMH usually involve widespread WM regions that contain long projection and association fasciculi connecting various cortical regions.37
Our second major finding was that SVD burden was associated with frontal/temporoparietal atrophy and frontal-executive/memory dysfunctions via disruption of the corresponding WM network. We have noted that decreased nodal efficiency and cortical atrophy regions related to WMH are similar; this indicates that the disrupted WM network might be a key link between SVD burden and cortical atrophy. That is, cerebral hypoperfusion induced by SVD leads to ischemia in WM regions, causing demyelination and axonal loss of the WM network, which in turn results in secondary damage to neuronal cell bodies and gray matter atrophy. It is generally accepted that when brain axons are injured, degeneration of the neuron occurs both proximally (dying back) and distally (Wallerian degeneration).38,39 Therefore, our findings suggest that SVD burden affects the WM network in the frontal and temporoparietal regions, resulting in corresponding cortical atrophy and eventually cognitive dysfunction. Alternatively, it is also possible that an ischemic process that affects gray matter and causes loss of neuronal cell bodies that have high metabolic demands leads to axonal degeneration, measured as WM network disruption and WMH. The sequential order and cause-effect relationships between gray matter loss and WM damage need to be investigated with longitudinal studies.
We also found that the disrupted frontal WM network affected frontal-executive dysfunction without mediating frontal atrophy. We previously reported that WMH independently affected cognitive impairment regardless of cortical atrophy.12 Our findings are in line with a recent study that showed that disturbances in WM connectivity explained a substantial proportion of the variance in cognitive function on top of markers of brain atrophy.10 Furthermore, we found that lacunes affected frontal-executive dysfunction without mediating the WM network or causing cortical atrophy in the frontal lobe.
In contrast to SVD burden, amyloid burden affected cognitive impairment without mediating the structural WM network. This trend was observed when we performed path analyses for both memory score and executive score. Although a previous study suggested that patients with AD had a disrupted WM network,9 the amyloid burden was not quantified, thus the results may have been derived from combined WM lesions. Our findings suggest that the WM network might be unaffected by amyloid when the SVD burden is thoroughly controlled.
There are several limitations to our study. First, we used a single diffusion tensor–based deterministic tractography algorithm, which does not detect fiber crossings. For future studies, advanced high angular resolution diffusion imaging methods40 should be used. Second, because of the cross-sectional nature of the study, we could only suggest associations. Further longitudinal studies are needed. Third, PiB-PET may not be sufficiently sensitive to detect soluble amyloid oligomers, diffuse amyloid plaques, or neurofibrillary tangle-predominant AD. Fourth, brain nodes related to frontal-executive or memory functions are widely distributed and parcellating functional areas based on an anatomical atlas may create some bias. Finally, our path analyses did not unravel their direct causative sequence. Nevertheless, our findings have implications for understanding how abnormalities in WM connectivity underlie the relationship between amyloid/SVD burden and cognition.
AUTHOR CONTRIBUTIONS
Dr. Sang Won Seo had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Hee Jin Kim, Kiho Im, Jong-Min Lee, and Sang Won Seo. Acquisition, analysis, or interpretation of data: Na-Yeon Jung, Yeo Jin Kim, Changsoo Kim, Hanna Cho, Byoung Seok Ye, Young Noh, Geon Ha Kim, En-Da Ko, Yearn Seong Choe, Kyung Han Lee, Sung Tae Kim, Jae Seung Kim. Critical revision of the manuscript for important intellectual content: Jae Hong Lee, Michael Ewers, Michael W. Weiner, Duk L. Na. Drafting of the manuscript: Sang Won Seo and Hee Jin Kim.
STUDY FUNDING
This study was supported by the Basic Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2065365), by the Korean Healthcare Technology R&D Project Ministry for Health & Welfare Affairs (HI10C2020 & HIC120713), by the Korea Ministry of Environment (MOE) as the Environmental Health Action Program (2014001360002), by the KOSEF NRL program grant (MEST; 2011-0028333), by Samsung Medical Center (CRL-108011 & CRS110-14-1), and by the Converging Research Center Program through the Ministry of Science, ICT and Future Planning, Korea (2013K000338).
DISCLOSURE
The authors report no disclosures relevant to the manuscript. Go to Neurology.org for full disclosures.
Footnotes
↵* These authors contributed equally to this work.
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Editorial, page 16
Supplemental data at Neurology.org
- Received September 23, 2014.
- Accepted in final form February 5, 2015.
- © 2015 American Academy of Neurology
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- Schneider JA,
- Arvanitakis Z,
- Bang W,
- Bennett DA
- 5.↵
- Lee JH,
- Kim SH,
- Kim GH,
- et al
- 6.↵
- 7.↵
- He Y,
- Chen Z,
- Evans A
- 8.↵
- 9.↵
- Lo CY,
- Wang PN,
- Chou KH,
- Wang J,
- He Y,
- Lin CP
- 10.↵
- Reijmer YD,
- Leemans A,
- Caeyenberghs K,
- et al
- 11.↵
- 12.↵
- 13.↵
- 14.↵
- McKhann G,
- Drachman D,
- Folstein M,
- Katzman R,
- Price D,
- Stadlan EM
- 15.↵
- 16.↵
- Fazekas F,
- Kleinert R,
- Offenbacher H,
- et al
- 17.↵
- 18.↵
- Jeon S,
- Yoon U,
- Park JS,
- et al
- 19.↵
- 20.↵
- 21.↵
- 22.↵
- Wang R,
- Beener T,
- Sorensen AG,
- Wedeen VJ
- 23.↵
- Hagmann P,
- Sporns O,
- Madan N,
- et al
- 24.↵
- Reijmer YD,
- Freeze WM,
- Leemans A,
- Biessels GJ
- 25.↵
- Shu N,
- Liu Y,
- Li K,
- et al
- 26.↵
- 27.↵
- Kang Y,
- Na DL
- 28.↵
- 29.↵
- 30.↵
- Lee DY,
- Fletcher E,
- Martinez O,
- et al
- 31.↵
- Tullberg M,
- Fletcher E,
- DeCarli C,
- et al
- 32.↵
- 33.↵
- Cavanna AE,
- Trimble MR
- 34.↵
- 35.↵
- 36.↵
- 37.↵
- 38.↵
- 39.↵
- Schallert T,
- Jones TA,
- Lindner MD
- 40.↵
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.